A new trading day began on Monday, with Olema Pharmaceuticals Inc (NASDAQ: OLMA) stock price up 8.11% from the previous day of trading, before settling in for the closing price of $23.17. OLMA’s price has ranged from $2.86 to $27.17 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -83.00%. Meanwhile, its annual earnings per share averaged 11.16%. With a float of $55.33 million, this company’s outstanding shares have now reached $68.65 million.
Olema Pharmaceuticals Inc (OLMA) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Olema Pharmaceuticals Inc is 19.42%, while institutional ownership is 86.06%. The most recent insider transaction that took place on Sep 18 ’25, was worth 83,300. In this transaction Director of this company sold 10,000 shares at a rate of $8.33, taking the stock ownership to the 744,140 shares. Before that another transaction happened on Sep 16 ’25, when Company’s Director sold 10,000 for $8.04, making the entire transaction worth $80,400. This insider now owns 754,140 shares in total.
Olema Pharmaceuticals Inc (OLMA) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.51 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.30% during the next five years compared to -83.00% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Here are Olema Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.81, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -2.33 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Looking closely at Olema Pharmaceuticals Inc (NASDAQ: OLMA), its last 5-days average volume was 25.8 million, which is a jump from its year-to-date volume of 1.52 million. As of the previous 9 days, the stock’s Stochastic %D was 80.57%.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 90.70%, which indicates a significant increase from 89.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.12 in the past 14 days, which was higher than the 0.76 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.35, while its 200-day Moving Average is $6.21. However, in the short run, Olema Pharmaceuticals Inc’s stock first resistance to watch stands at $25.90. Second resistance stands at $26.75. The third major resistance level sits at $28.41. If the price goes on to break the first support level at $23.39, it is likely to go to the next support level at $21.72. Should the price break the second support level, the third support level stands at $20.87.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
With a market capitalization of 1.72 billion, the company has a total of 68,660K Shares Outstanding. Currently, annual sales are 0 K while annual income is -129,470 K. The company’s previous quarter sales were 0 K while its latest quarter income was -42,220 K.
